about
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsi...
Read More
37.78
-1.34
(-3.43%)
315.8K
XNAS Volume
XNAS 15 Jan, 2026 4:11 PM (EST)
High Financial Strength
Affordable Valuation
Technically Neutral
Strong Performer, Under Radar
These stocks have good quality scores and strong financials. They are affordably priced stocks with potential for good returns
View Similar
Embed DVM
Rigel Pharma Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..